SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma

SIMPLE SUMMARY: The SAINT study is an early-stage clinical trial based on the hypothesis that immunotherapy is more effective when given earlier in the course of the disease in patients with advanced soft tissue sarcoma. It consists of two parts. Phase I aims to determine the maximum acceptable dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Erlinda Maria, Chawla, Sant P., Tellez, Walter Andree, Younesi, Elan, Thomas, Sonu, Chua-Alcala, Victoria S., Chomoyan, Hripsime, Valencia, Chrysler, Brigham, Don Arlen, Moradkhani, Ania, Quon, Doris, Srikureja, Amornchit, Wong, Steven G., Tseng, William, Federman, Noah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913367/
https://www.ncbi.nlm.nih.gov/pubmed/36765863
http://dx.doi.org/10.3390/cancers15030906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913367/
https://www.ncbi.nlm.nih.gov/pubmed/36765863
http://dx.doi.org/10.3390/cancers15030906

Ejemplares similares